Sweet’s Syndrome Induced by Aromatase Inhibitor in the Treatment of Early Breast Cancer

BACKGROUND: Breast cancer is the most commonly diagnosed cancer in women, mainly at an early stage, allowing treatment with curative intent. Aromatase inhibitors are widely used in the adjuvant treatment of oestrogen receptor-positive breast cancer, mainly in postmenopausal women. The most frequent...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardoso, Debora, Coelho, Andreia, Fernandes, Leonor, Matos, Leonor Vasconcelos, Serrano, Isabel, Miranda, Helena, Martins, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083188/
https://www.ncbi.nlm.nih.gov/pubmed/32206641
http://dx.doi.org/10.12890/2020_001435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083188/
https://www.ncbi.nlm.nih.gov/pubmed/32206641
http://dx.doi.org/10.12890/2020_001435

Ejemplares similares